Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center.
A. M. Molina
Research Funding - Novartis
X. Jia
No relevant relationships to disclose
M. S. Ginsberg
No relevant relationships to disclose
S. Velasco
No relevant relationships to disclose
D. R. Feldman
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
S. Patil
No relevant relationships to disclose
R. J. Motzer
Research Funding - Pfizer